Msheik Ali, Gerges Teddy, Al Mokdad Zeinab, Abbass Daniel, Mohanna Assaad, Aoude Ahmad
Neurological Surgery, Lebanese University Faculty of Medicine, Hadath, LBN.
Anesthesia, Winchester Anesthesia Associates, Boston, USA.
Cureus. 2023 May 30;15(5):e39733. doi: 10.7759/cureus.39733. eCollection 2023 May.
Chronic subdural hematoma (cSDH) is a common condition that typically requires surgical intervention. Middle meningeal artery embolization (MMAE) has emerged as a potential alternative treatment option, although the choice of embolization material remains a topic of debate. In this case series, we report on the outcomes of 10 patients with cSDH who underwent MMAE. Most patients experienced symptom relief and a significant reduction in cSDH size post-procedure. Despite the presence of comorbidities and risk factors, most patients had positive outcomes following MMAE treatment. Only one patient required surgical intervention after the MMAE procedure due to the progression of symptoms, while MMAE successfully prevented recurrence in most patients. Our findings suggest that MMAE can be a promising treatment option for selected patients with cSDH. However, further studies are needed to compare the efficacy and safety of different embolization materials in MMAE procedures for cSDHs.
慢性硬膜下血肿（cSDH）是一种常见病症，通常需要手术干预。脑膜中动脉栓塞术（MMAE）已成为一种潜在的替代治疗选择，尽管栓塞材料的选择仍是一个有争议的话题。在本病例系列中，我们报告了10例接受MMAE治疗的cSDH患者的治疗结果。大多数患者术后症状缓解，cSDH大小显著减小。尽管存在合并症和风险因素，但大多数患者在接受MMAE治疗后预后良好。MMAE术后只有1例患者因症状进展需要手术干预，而MMAE成功预防了大多数患者的复发。我们的研究结果表明，对于部分cSDH患者，MMAE可能是一种有前景的治疗选择。然而，需要进一步研究来比较不同栓塞材料在cSDH的MMAE手术中的疗效和安全性。
